Eye News and Research

Latest Eye News and Research

Phase 3 clinical trial commences to evaluate antiviral for monkeypox

A Phase 3 clinical trial evaluating the antiviral tecovirimat, also known as TPOXX, is now enrolling adults and children with monkeypox infection in the United States.

9 Sep 2022

NIH funds $3.35 million to enhance diversity in genomics training

The National Human Genome Research Institute (NHGRI), part of the National Institutes of Health, will fund $3.35 million over five years to launch the Genome Research Experiences to Attract Talented Undergraduates into the Genomics Field to Enhance Diversity (GREAT) program.

9 Sep 2022

Researchers produce high-resolution crystal structure of enzyme critical to SARS-CoV-2 survival

A team of Mount Sinai researchers has produced a high-resolution crystal structure of an enzyme essential to the survival of SARS-CoV-2, the virus that causes COVID-19.

9 Sep 2022

New gene therapy approach could help prevent blindness in children with Leber congenital amaurosis

Researchers from the National Eye Institute have developed a gene therapy that rescues cilia defects in retinal cells affected by a type of Leber congenital amaurosis (LCA), a disease that causes blindness in early childhood.

8 Sep 2022

Clinical trial begins evaluating alternative strategies to administer the JYNNEOS monkeypox vaccine

A clinical trial evaluating alternative strategies for administering the JYNNEOS monkeypox vaccine to increase the number of available doses has begun enrolling adult volunteers.

8 Sep 2022

Techniques used for SARS-CoV-2 detection in body fluids

In a recent review published in the journal Trends in Analytical Chemistry, researchers provided a comprehensive overview of the current techniques used for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) detection in bodily fluids.

7 Sep 2022

Study helps reveal the molecular secrets of macular degeneration

Research led by Sanford Burnham Prebys professor Francesca Marassi, Ph.D., is helping to reveal the molecular secrets of macular degeneration, which causes almost 90% of all age-related vision loss.

7 Sep 2022

Low-dose ketamine is safe and effective to treat children with ADNP syndrome, study suggests

Results of a small, but unique research study, led by researchers from the Seaver Autism Center for Research and Treatment at Mount Sinai and published online in Human Genetics and Genomic Advances, suggest that low-dose ketamine is generally safe, well-tolerated and effective to treat clinical symptoms in children diagnosed with ADNP syndrome (also known as Helsmoortel-VanDerAa syndrome), a rare neurodevelopmental disorder caused by mutations in the activity dependent neuroprotective protein (ADNP) gene.

6 Sep 2022

Exposure to blue light may accelerate aging

A new study provides insights into the novel mechanisms through which blue light exposure interferes with non-retinal cell metabolic pathways in flies.

5 Sep 2022

Study shows encouraging therapeutic options for patients with relapsed multiple myeloma

Mount Sinai researchers have published results that show encouraging therapeutic options for patients with the blood cancer multiple myeloma after first-line treatment with bispecific antibodies fails.

1 Sep 2022

The currently available evidence on viral-induced parkinsonism

A new review attempts to summarize all known about the relationship between viral illness and parkinsonian disorders to facilitate further research.

31 Aug 2022

Brain activity patterns during sleep shed light on the neurobiology behind 22q11.2 Deletion Syndrome

The brain activity patterns during sleep shed light on the neurobiology behind a genetic condition called 22q11.2 Deletion Syndrome (22q11.2DS) and could be used as a biomarker to detect the onset of neuropsychiatric disorders in people with 22q11.2DS.

30 Aug 2022

The first dose response for SARS-CoV-2 solution exposed to UV222

Researchers used culture and molecular assays to provide the first dose-response for SARS-CoV-2 solution exposed to UV222.

30 Aug 2022

Individuals with early-onset diabetes, hypertension more likely to develop primary open-angle glaucoma

The earlier individuals develop Type 2 diabetes or hypertension in life, the earlier they are likely to develop primary open-angle glaucoma (POAG), the leading cause of irreversible blindness worldwide, researchers from UT Southwestern reported in a recent study.

29 Aug 2022

Music intervention can help bridge the gap between dementia patients and their loved ones

People with dementia often lose their ability to communicate verbally with loved ones in later stages of the disease.

29 Aug 2022

Novel method for accurate diagnosis and treatment of uveitis

An estimated five to ten percent of blindness worldwide is caused by the rare inflammatory eye disease uveitis. Posterior uveitis in particular is often associated with severe disease progression and the need for immunosuppressive therapy.

29 Aug 2022

New risk assessment tool predicts mortality for atrial fibrillation patients after completion of TAVR

A large-scale international study led by Mount Sinai has yielded the first risk score that can help predict mortality for patients with atrial fibrillation (AFib) who have undergone a successful transcatheter aortic valve replacement (TAVR) and discharged home.

29 Aug 2022

Over 50 new surgical hubs to open across England to help bust COVID-19 backlogs, Steve Barclay writes

Health and Social Care Secretary Steve Barclay wrote in Times Red Box about the new surgical hubs that will open across the country to help bust the COVID-19 backlogs.

26 Aug 2022

Mouse embryoids offer a promising model system to spur research into embryonic development and disease

Scientists funded in part by the National Institutes of Health have generated a mouse embryo model, or embryoid, that develops beyond neurulation—formation of the neural tube, which gives rise to the central nervous system—and closely mirrors natural mouse embryos 8.5 days after fertilization.

25 Aug 2022

Study offers a glimpse into the ongoing cognitive processes in the sleeping brain

When our eyes move during REM sleep, we're gazing at things in the dream world our brains have created, according to a new study by researchers at UC San Francisco.

25 Aug 2022

Eye News and Research

Latest Eye News and Research

Phase 3 clinical trial commences to evaluate antiviral for monkeypox

NIH funds $3.35 million to enhance diversity in genomics training

Researchers produce high-resolution crystal structure of enzyme critical to SARS-CoV-2 survival

New gene therapy approach could help prevent blindness in children with Leber congenital amaurosis

Clinical trial begins evaluating alternative strategies to administer the JYNNEOS monkeypox vaccine

Techniques used for SARS-CoV-2 detection in body fluids

Study helps reveal the molecular secrets of macular degeneration

Low-dose ketamine is safe and effective to treat children with ADNP syndrome, study suggests

Exposure to blue light may accelerate aging

Study shows encouraging therapeutic options for patients with relapsed multiple myeloma

The currently available evidence on viral-induced parkinsonism

Brain activity patterns during sleep shed light on the neurobiology behind 22q11.2 Deletion Syndrome

The first dose response for SARS-CoV-2 solution exposed to UV222

Individuals with early-onset diabetes, hypertension more likely to develop primary open-angle glaucoma

Music intervention can help bridge the gap between dementia patients and their loved ones

Novel method for accurate diagnosis and treatment of uveitis

New risk assessment tool predicts mortality for atrial fibrillation patients after completion of TAVR

Over 50 new surgical hubs to open across England to help bust COVID-19 backlogs, Steve Barclay writes

Mouse embryoids offer a promising model system to spur research into embryonic development and disease

Study offers a glimpse into the ongoing cognitive processes in the sleeping brain

Innovation in neuroscience drug discovery - eBook eBook

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Eye News and Research

Latest Eye News and Research

Innovation in neuroscience drug discovery - eBook eBook

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Newsletters you may be interested in